Anti-REEP6 monoclonal antibody

Pre-made anti-REEP6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to REEP6/REEP6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1483-Ab-1/ GM-Tg-hg-IP1483-Ab-2Anti-Human REEP6 monoclonal antibodyHuman
GM-Tg-rg-IP1483-Ab-1/ GM-Tg-rg-IP1483-Ab-2Anti-Rat REEP6 monoclonal antibodyRat
GM-Tg-mg-IP1483-Ab-1/ GM-Tg-mg-IP1483-Ab-2Anti-Mouse REEP6 monoclonal antibodyMouse
GM-Tg-cynog-IP1483-Ab-1/ GM-Tg-cynog-IP1483-Ab-2Anti-Cynomolgus/ Rhesus macaque REEP6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1483-Ab-1/ GM-Tg-felg-IP1483-Ab-2Anti-Feline REEP6 monoclonal antibodyFeline
GM-Tg-cang-IP1483-Ab-1/ GM-Tg-cang-IP1483-Ab-2Anti-Canine REEP6 monoclonal antibodyCanine
GM-Tg-bovg-IP1483-Ab-1/ GM-Tg-bovg-IP1483-Ab-2Anti-Bovine REEP6 monoclonal antibodyBovine
GM-Tg-equg-IP1483-Ab-1/ GM-Tg-equg-IP1483-Ab-2Anti-Equine REEP6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1483-Ab-1/ GM-Tg-hg-IP1483-Ab-2; GM-Tg-rg-IP1483-Ab-1/ GM-Tg-rg-IP1483-Ab-2;
GM-Tg-mg-IP1483-Ab-1/ GM-Tg-mg-IP1483-Ab-2; GM-Tg-cynog-IP1483-Ab-1/ GM-Tg-cynog-IP1483-Ab-2;
GM-Tg-felg-IP1483-Ab-1/ GM-Tg-felg-IP1483-Ab-2; GM-Tg-cang-IP1483-Ab-1/ GM-Tg-cang-IP1483-Ab-2;
GM-Tg-bovg-IP1483-Ab-1/ GM-Tg-bovg-IP1483-Ab-2; GM-Tg-equg-IP1483-Ab-1/ GM-Tg-equg-IP1483-Ab-2
Products NameAnti-REEP6 monoclonal antibody
Formatmab
Target NameREEP6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-REEP6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1483-Ag-1Recombinant multi-species REEP6/ C19orf32/ DP1L1.1 protein


    Target information

    Target IDGM-IP1483
    Target NameREEP6
    Gene ID92840,70335,362835,707662,612290,101097950,522480,100146126
    Gene Symbol and Synonyms0610011M24Rik,C19orf32,DP1L1,REEP6,REEP6.1,REEP6.2,RP77,TB2L1,Yip2f
    Uniprot AccessionQ96HR9,Q5XI60,Q32LG5
    Uniprot Entry NameREEP6_HUMAN,REEP6_RAT,REEP6_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000115255
    Target ClassificationN/A

    The target: REEP6, gene name: REEP6, also named as C19orf32, DP1L1.1, REEP6.2, RP77, TB2L1, Yip2f, REEP6. The protein encoded by this gene may be involved in the transport of receptors from the endoplasmic reticulum (ER) to the cell surface. The encoded protein may also play a role in regulating ER membrane structure. This gene is required for the proper development of retinal rods and photoreceptors, with defects in this gene being associated with retinitis pigmentosa 77. [provided by RefSeq, May 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.